Form 4 for TCRT Alaunos Therapeutics, Inc.
Accepted 2026-07-02 17:33:32 ET · period of report 2026-06-30 · accession 0001193125-26-295004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-02 17:33 | 2026-06-30 | TCRT | Weis Holger | CEO | A - Grant | $2.26 | +3,880 | 16.6K | +31% | +$8,769 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-30 | A | A | 3,880 | $2.26 | 16,552 | D | — | — | (F1) Represents shares of common stock issued in lieu of net salary. |